Powl Brian T. 4

What Happened
Brian T. Powl, Chief Commercial Officer of Kura Oncology (KURA), sold a total of 6,414 shares on 2026-01-27 in two open-market transactions at $8.46 per share. The sales were for 4,842 shares ($40,966) and 1,572 shares ($13,300), totaling approximately $54,266. These were disposals (sales), not purchases — specifically sell-to-cover transactions to satisfy tax withholding on vested restricted stock units (RSUs).

Key Details

• Transaction date and price: 2026-01-27, both lots at $8.46 per share.
• Shares sold: 4,842 and 1,572 (total 6,414 shares). Total proceeds ≈ $54,266.
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnotes: F1 and F2 state these were sell-to-cover transactions for taxes on RSUs that vested on 1/2/25 and 1/2/24, respectively. (Transaction code S; tax withholding F.)
• Filing timeliness: report filed with an accession date of 2026-01-27, the same date as the reported transactions (no late filing indicated in the provided data).

Context: Sell-to-cover transactions are routine tax-withholding sales tied to RSU vesting and do not necessarily signal an executive view on the company's stock. Purchases or open-market acquisitions generally carry more weight as indicators of insider bullishness.